fibrose

简明释义

英[faɪˈbrəʊs]美[ˈfaɪbroʊs]

形成纤维性组织

英英释义

单词用法

同义词

反义词

例句

1.Vaidisova decided that she gives support to "Club of sick by cystic fibrose" which helps to people who sick by this illness and their families.

瓦娃决定支援一个帮助患有这种病的人和他们的家庭的叫做“囊肿性纤维化病人俱乐部”。

2.Vaidisova decided that she gives support to "Club of sick by cystic fibrose" which helps to people who sick by this illness and their families.

瓦娃决定支援一个帮助患有这种病的人和他们的家庭的叫做“囊肿性纤维化病人俱乐部”。

3.The biopsy revealed significant fibrose 纤维化 in the tissue samples.

活检显示组织样本中有显著的纤维化 纤维化。

4.The patient's lungs showed signs of fibrose 纤维化, indicating a chronic condition.

患者的肺部显示出纤维化 纤维化的迹象，表明存在慢性疾病。

5.Doctors are studying the effects of fibrose 纤维化 on liver function in patients with hepatitis.

医生们正在研究在肝炎患者中，纤维化 纤维化对肝功能的影响。

6.Patients with fibrose 纤维化 often require specialized care and monitoring.

患有纤维化 纤维化的患者通常需要专业护理和监测。

7.Early detection of fibrose 纤维化 can lead to better treatment outcomes.

早期发现纤维化 纤维化可以带来更好的治疗效果。

作文

Fibrosis is a medical condition characterized by the excessive formation of fibrous connective tissue in an organ or tissue, leading to its dysfunction. This condition can arise from various causes such as chronic inflammation, injury, or exposure to certain toxins. Understanding the implications of fibrose (纤维化) is essential for both patients and healthcare providers, as it can significantly affect the quality of life and overall health outcomes. The process of fibrose (纤维化) involves the activation of fibroblasts, which are cells responsible for producing collagen and other extracellular matrix components. When these cells become overly activated, they can lead to an accumulation of collagen that disrupts the normal architecture of tissues. This can result in stiffness and scarring, which may impair the function of the affected organ. For example, in the lungs, fibrose (纤维化) can lead to conditions such as pulmonary fibrosis, where the lung tissue becomes thickened and stiff, making it difficult for patients to breathe. In addition to the lungs, fibrose (纤维化) can occur in other organs, including the liver, heart, and kidneys. Each type of fibrosis presents unique challenges and symptoms. In liver fibrosis, for instance, the liver tissue may become scarred due to chronic liver disease, resulting in complications like cirrhosis. In cardiac fibrosis, the heart muscle can become stiff, leading to heart failure. The diagnosis of fibrose (纤维化) typically involves imaging studies, blood tests, and sometimes biopsies to assess the extent of tissue damage. Early detection is crucial, as it allows for timely intervention. Treatment options may vary depending on the underlying cause of the fibrosis. For instance, if the fibrosis is due to an autoimmune condition, immunosuppressive medications may be prescribed. In cases where the fibrosis is related to environmental factors, such as occupational exposure to harmful substances, eliminating the source of exposure is vital. Research into fibrose (纤维化) is ongoing, with scientists exploring new therapeutic approaches to halt or reverse the fibrotic process. Some studies are focusing on antifibrotic agents that can inhibit the activity of fibroblasts or promote their apoptosis (programmed cell death). Additionally, stem cell therapy is being investigated as a potential treatment to regenerate damaged tissues and reduce fibrosis. Living with fibrose (纤维化) can be challenging for patients, as it often requires lifestyle modifications and ongoing medical care. Support from healthcare professionals, family, and support groups can play a crucial role in managing this condition. Patients are encouraged to stay informed about their health and engage in discussions with their healthcare providers about the best strategies for managing their specific type of fibrosis. In conclusion, fibrose (纤维化) is a complex condition with significant implications for affected individuals. A comprehensive understanding of its causes, symptoms, and treatment options is essential for effective management. As research continues to advance, there is hope for improved therapies and outcomes for those living with this challenging condition.

纤维化是一种医疗状况，其特征是器官或组织中纤维结缔组织的过度形成，导致其功能障碍。这种情况可能由多种原因引起，例如慢性炎症、损伤或接触某些毒素。理解纤维化（fibrose）的影响对患者和医疗提供者至关重要，因为它可能显著影响生活质量和整体健康结果。纤维化（fibrose）过程涉及成纤维细胞的激活，这些细胞负责产生胶原蛋白和其他细胞外基质成分。当这些细胞过度激活时，会导致胶原蛋白的积累，破坏组织的正常结构。这可能导致僵硬和瘢痕，从而影响受影响器官的功能。例如，在肺部，纤维化（fibrose）可能导致肺纤维化等疾病，肺组织变得厚实和僵硬，使患者呼吸困难。除了肺部，纤维化（fibrose）还可以发生在其他器官，包括肝脏、心脏和肾脏。每种类型的纤维化都有其独特的挑战和症状。例如，在肝纤维化中，由于慢性肝病，肝组织可能变得有瘢痕，导致并发症如肝硬化。在心脏纤维化中，心肌可能变得僵硬，导致心力衰竭。纤维化（fibrose）的诊断通常涉及影像学检查、血液测试，有时还包括活检以评估组织损伤的程度。早期发现至关重要，因为这可以及时干预。治疗选择可能因纤维化的根本原因而异。例如，如果纤维化是由于自身免疫疾病引起的，可能会开处方免疫抑制药物。在与环境因素相关的纤维化病例中，消除暴露源至关重要。对纤维化（fibrose）的研究正在进行中，科学家们正在探索新的治疗方法，以阻止或逆转纤维化过程。一些研究集中在抗纤维化药物上，这些药物可以抑制成纤维细胞的活动或促进其凋亡（程序性细胞死亡）。此外，干细胞疗法也正在被研究作为一种潜在的治疗方法，以再生受损组织并减少纤维化。与纤维化（fibrose）共存对患者来说可能是具有挑战性的，因为这通常需要生活方式的调整和持续的医疗护理。来自医疗专业人士、家庭和支持小组的支持在管理这种情况中发挥着至关重要的作用。鼓励患者了解自己的健康状况，并与医疗提供者讨论管理特定类型纤维化的最佳策略。总之，纤维化（fibrose）是一种复杂的疾病，对受影响个体有重大影响。全面理解其原因、症状和治疗选择对于有效管理至关重要。随着研究的不断进展，对于那些生活在这种挑战性疾病中的人们来说，改善疗法和结果的希望依然存在。